ApoE-4-Träger mit MCI profitieren von Homotaurin-Prodrug

InFo Neurologie + Psychiatrie 2026

View at publisher

Authors: Thomas Müller

DOI: 10.1007/s15005-026-4637-z

Cited by: 0

Fields of Study & Subjects

Alzheimer's disease research and treatments Dementia and Cognitive Impairment Research Neurological Disorders and Treatments